Research

Mixed

Systems-oriented functional profiling (phenotypic/omics) and chemical fingerprinting of phytochemicals provide a more rational basis for evaluating plant-derived T2D pharmacotherapies than traditional target-centric approaches.

For those interested in plant-based approaches to diabetes, the scientific community is moving towards understanding how whole plant extracts work through multiple pathways rather than just one. This suggests that standardized, well-analyzed botanical preparations may offer benefits that single-molecule drugs do not, particularly in addressing the complex, multi-factorial nature of Type 2 Diabetes.

ModerateSupportsMEDIUM confidence
More holistic, systems-oriented profiling of phytochemicals with functional-biology, omics, and chemical-fingerprinting tools now appears necessary to increase our appreciation of phytometabolite actions potentially beneficial to the T2D patient.
David R. Janero · Expert Opinion on Pharmacotherapy · 2013

Why this rating

This is a perspective/commentary paper citing existing literature and regulatory precedents, not a primary clinical trial.

Source

Relieving the cardiometabolic disease burden: a perspective on phytometabolite functional and chemical annotation for diabetes management

David R. Janero · Expert Opinion on Pharmacotherapy · 2013

DOI 10.1517/14656566.2014.852538

narrative_reviewCited 6×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →